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Background: The enzyme ghrelin O-acyltransferase (GOAT) catalyzes the acylation of
ghrelin. The molecular form of GOAT, together with its reaction in vitro, has been reported
previously. However, the subcellular processes governing the acylation of ghrelin remain
to be elucidated.
Methods: Double immunoelectron microscopy was used to examine changes in the
relative proportions of secretory granules containing n-octanoyl ghrelin (C8-ghrelin) or n-
decanoyl ghrelin (C10-ghrelin) in ghrelin-producing cells of mouse stomachs.The dynamics
of C8-type (possessing C8-ghrelin exclusively), C10-type (possessing C10-ghrelin only),
and mixed-type secretory granules (possessing both C8- and C10-ghrelin) were investi-
gated after fasting for 48 h or after 2 weeks feeding with chow containing glyceryl-tri-
octanoate (C8-MCT) or glyceryl-tri-decanoate (C10-MCT). The dynamics of C8- or C10-
ghrelin-immunoreactivity (ir-C8- or ir-C10-ghrelin) within the mixed-type granules were also
investigated.
Results: Immunoelectron microscopic analysis revealed the co-existence of C8- and C10-
ghrelin within the same secretory granules (mixed-type) in ghrelin-producing cells. Com-
pared to control mice fed standard chow, the ratio of C10-type secretory granules increased
significantly after ingestion of C10-MCT, whereas that of C8-type granules declined signif-
icantly under the same treatment. After ingestion of C8-MCT, the proportion of C8-type
secretory granules increased significantly. Within the mixed-type granules the ratio of ir-
C10-ghrelin increased significantly and that of ir-C8-ghrelin decreased significantly upon
fasting.
Conclusion:These findings confirmed that C10-ghrelin, another acyl-form of active ghrelin,
is stored within the same secretory granules as C8-ghrelin, and suggested that the types of
medium-chain acyl-molecules surrounding and available to the ghrelin-GOAT system may
affect the physiological processes of ghrelin acylation.
Keywords: decanoyl ghrelin, fasting, ghrelinO-acyltransferase, immunoelectron microscopy, medium-chain triglyc-
erides, octanoyl ghrelin, radioimmunoassay, secretory granules
INTRODUCTION
Ghrelin is an acylated peptide hormone mainly produced in the
stomach (1). A main acyl-form of ghrelin in rodents and humans
is an n-octanoyl ghrelin (C8-ghrelin), a serine 3 residue (Ser3)
of which is modified by an n-octanoic acid (2, 3). The acylation
of ghrelin is catalyzed by an enzyme: ghrelin O-acyltransferase
(GOAT: previously known as MBOAT4) that belongs to the super-
family of membrane-bound O-acyltransferase (MBOAT) (4, 5).
Since the discovery of GOAT (6, 7), many in vitro and in vivo
studies on the mechanism of ghrelin acylation by this enzyme
have been carried out (8–11). However, several discrepancies have
emerged between the in vitro and in vivo findings (5, 12). For
example, as regards the stomach content of acyl-ghrelins modi-
fied by a fatty acid with a carbon-chain shorter or a longer than
eight (C8), we have detected a very low content of n-hexanoyl
ghrelin (C6-ghrelin) in stomachs of mice under physiological
conditions (i.e., without the ingestion of glyceryl-tri-hexanoate:
a medium-chain triglyceride (MCTs) composed of three sets of
n-hexanoyl group, C6-MCT) (13). We have also detected a con-
siderable amount of n-decanoyl ghrelin (C10-ghrelin) in stomachs
of mice, rabbits, or golden hamster fed ad libitum a standard
chow (12). Furthermore, after fasting, the content of C10-ghrelin
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in mouse stomachs increased to nearly one third that of C8-
ghrelin (14). These observations in vivo did not match the findings
in vitro showing that GOAT has a preference for n-hexanoyl-CoA
(C6-CoA) over n-octanoyl-CoA (C8-CoA), and also has greater
preference for C8-CoA than n-decanoyl-CoA (C10-CoA) as an
acyl donor (9).
Several groups have used immunoelectron microscopy to study
the subcellular distribution of ghrelin (15–17) and ghrelin-related
molecules (18, 19). However, there have been no reports concern-
ing the distributional changes of acyl-ghrelins within ghrelin-
producing cells (subcellular dynamics of acyl-ghrelins) under
different nutritional conditions.
The present study used double immunoelectron microscopy
to confirm the subcellular distribution of C8- and C10-ghrelins
within ghrelin-producing cells. To shed light on the subcellu-
lar processes of ghrelin acylation, changes in the distribution
of C8- or C10-ghrelin in ghrelin-producing cells were inves-
tigated after fasting or after ingestion of glyceryl-tri-octanoate
(C8-MCT) or glyceryl-tri-decanoate (C10-MCT). In order to
relate the present electron microscopic findings to the biochem-
ical findings reported previously (11, 13, 14, 20), we also exam-
ined the change in stomach contents of C8- or C10-ghrelin
by respective radioimmunoassay system (RIA), and studied the
changes of ghrelin and GOAT mRNA levels in the mouse
stomach.
MATERIALS AND METHODS
ANIMALS
Male C57BL/6J mice (Jcl: C57BL/6J, CLEA Japan, Inc., Osaka,
Japan) weighing 20–25 g (10–13 weeks old) were used in this
study. The animals were maintained under controlled temperature
(24± 1°C), humidity (55± 5%), and light conditions (light on
07:00–19:00 h) with free access to standard laboratory chow (CE-
2, CLEA Co. Ltd., Osaka, Japan) and water. Stomach and plasma
samples from mice were obtained under anesthesia with sodium
pentobarbital 30 mg/kg i.p. (Nembutal™, Dainippon Pharmaceu-
tical Co., Ltd., Osaka, Japan). All experiments were undertaken
in accordance with the Guidelines for Animal Experimentation,
Kurume University.
SCHEDULE FOR THE INGESTION OF MEDIUM-CHAIN TRIGLYCERIDES
To examine the effect of dietary MCTs on the cellular distribu-
tion of stomach n-octanoyl ghrelin (C8-ghrelin) or n-decanoyl
ghrelin (C10-ghrelin), mice (n= 5 in each ingestion group) were
fed chow mixed with 3% (wt/wt) glyceryl-tri-octanoate or tri-
decanoate (C8-MCT or C10-MCT; Wako Pure Chemical, Osaka,
Japan) for 2 weeks as described previously (13, 21). The control
animals were fed a CE-2 pellet diet and water ad libitum. Body
weights of mice were measured before and after feeding with chow
containing C8- or C10-MCT (C8-MCT-fed or C10-MCT-fed),
and compared to those of control mice fed a standard labora-
tory chow ad libitum (Control). Daily food intake of the mouse
(g/day/mouse) in each feeding condition (C8-MCT, C10-MCT,
or Control) was also estimated by measuring the weight of chow
every 24 h-period.
SCHEDULE FOR FASTING EXPERIMENT
Prior to performing the fasting experiment, the mice had free
access to food and water. The fasting time was calculated from the
time when food was withdrawn on the first day of the experiment.
For the sampling from fasted mice (n= 5), food was withdrawn at
8:00 a.m. on the first day of the experiment and samples (stomach
and plasma) were obtained at 8:00 a.m. on the third day (two-
overnight) of the experiment. Body weights of mice before and
after fasting were measured and compared.
IMMUNOHISTOCHEMISTRY FOR C8- AND C10-GHRELIN
The fundi of the stomach in the control mice (fed with free access
to standard laboratory chow, n= 5), mice receiving chow with
glyceryl-tri-octanoate (C8-MCT, n= 5) or tri-decanoate (C10-
MCT, n= 5), and fasted mice (n= 5) were collected and fixed in
Zamboni’s solution and routinely embedded in paraffin. Immuno-
histochemical staining was performed according to the modified
avidin-biotin-peroxidase complex (ABC) technique described in
our previous report (17). For C8- and C10-ghrelin immunohis-
tochemical study, rabbit antiserum against C8-ghrelin diluted 1:
100,000 or rabbit antiserum against C10-ghrelin diluted 1:2000
was used as the primary antibody. Negative control studies were
performed with anti-C8- or C10-ghrelin antisera, each of which
had been abolished by 10µg of synthesized C8-ghrelin or C10-
ghrelin, respectively. Negative control studies were also done by
omitting antisera against C8-ghrelin or C10-ghrelin. These nega-
tive controls showed no immunoreactions. For light-microscopic
morphometry, three to five sections from each mouse stomach
(n= 5 mice in each group) were observed at random using an
ocular micrometer, and the number of immunopositive cells for
C8- or C10-ghrelin per unit area of glandular portions (mm2) was
counted.
DOUBLE IMMUNOFLUORESCENCE FOR C8- AND C10-GHRELIN
Immunofluorescent staining was performed according to the dou-
ble immunofluorescence technique described in our previous
report (17). For C8- and C10-ghrelin immunofluorescent study,
mouse monoclonal antibody against the N-terminal sequence of
C8-ghrelin (Mitsubishi Kagaku Iatron Inc., Tokyo, Japan) diluted
1:2000 and rabbit antiserum against C10-ghrelin diluted 1:3000
were used as the primary antibody, respectively. Three sections
from each mouse in control group were observed.
IMMUNOELECTRON MICROSCOPY FOR C8- OR C10-GHRELIN
Samples for immunoelectron microscopy were prepared as
described previously (17). Ultrathin sections were labeled by
the post-embedding double immunogold labeling method as
described previously (22) with slight modification. The double
immunogold labeling was carried out using the two polyclonal
antibodies against C8-ghrelin and C10-ghrelin. One face of a
section was incubated in rabbit anti-C8-ghrelin antibody diluted
1:2000, and anti-rabbit IgG (British Biocell International, Cardiff,
UK) conjugated with 20 nm gold particles (large particles) was
used for the immunogold labeling of this face of the section.
Rabbit anti-C10-ghrelin antibody (diluted 1:400) and anti-rabbit
IgG (British Biocell International) conjugated with 10 nm gold
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particles (small particles) were used for the immunogold labeling
of the other face of the section. For morphometric analysis, at least
10 electron micrographs of ghrelin cells were taken from each ani-
mal at a primary magnification of ×20,000 and printed at a final
magnification of ×50,000.
QUANTITATIVE IMMUNOELECTRON MICROSCOPIC ANALYSES FOR C8-
AND C10-GHRELIN
Immunogold ultrastructural morphometric analysis was done as
described in the previous reports (16, 23, 24). Approximately three
to five photographs of ghrelin-producing cells per section of fundi
were randomly selected from three to five sections per mouse in the
stomach of each mouse (over 100 images). Based on our previous
findings for the average diameter of ghrelin-positive granules in
mice (277± 11.1 nm) (17), we randomly chose secretory granules
of 250–300 nm diameter from one ghrelin-producing cell per pho-
tograph. The observed counts for immunogold-particles within a
single secretory granule were used to construct numerical and
percentage frequency distributions for C8- or C10-ghrelin in the
control, C8-MCT-fed, C10-MCT-fed, and fasted mice (n= 5 mice
in each group). Immunogold-labeled secretory granules contain-
ing only immunoreactivity for C8-ghrelin (large immunogold-
particles) were defined as C8-type; those showing immunoreac-
tivity only for C10-ghrelin (small immunogold particles) were
defined as C10-type; and those containing immunoreactivity for
both C8- and C10-ghrelin (both large and small immunogold
particles) were mixed-type. The number of secretory granules
(C8-, C10-, or mixed-type) in ghrelin-producing cells of C8-MCT-
fed, C10-MCT-fed, or fasted mice was counted (approximately
250 secretory granules per each group of mice), and the pro-
portion (%) of respective granule type was calculated within
ghrelin-producing cells from each group of mice (C8-MCT-fed,
C10-MCT-fed, fasted, or fed ad libitum; n= 5 mice in each group).
Furthermore, with regard to the mixed-type secretory granules
that were immunopositive for both C8- and C10-ghrelin, the
number of small immunogold particles (reflecting the C8-ghrelin-
immunoreactivity) and large immunogold particles (reflecting the
C10-ghrelin-immunoreactivity) within a single secretory granule
were counted separately, and the proportions of each type were
calculated relative to the total number (small plus large parti-
cles). The average rate of immunoreactivity for C8- or C10-ghrelin
within the mixed-type secretory granules was calculated from
three to five photographs of double immunoelectron microscopy
per mouse. Thereafter, the changes in the proportions of C8- or
C10-ghrelin-immunoreactivity per mixed-type secretory granule
were evaluated under fasting conditions and compared with the
results in control mice fed standard chow ad libitum (n= 5 mice
in each group).
RIAs FOR C8-GHRELIN, C10-GHRELIN, AND TOTAL GHRELIN
The RIA for C8- or C10-ghrelin (C8-ghrelin RIA, C10-ghrelin
RIA) was performed as described previously for rat and mouse
ghrelin (14, 25, 26). The anti-C8-ghrelin antiserum exhibited
100% cross-reactivity with rat, mouse, and human C8-ghrelin
but does not recognize des-acyl-ghrelin. The anti-C10-ghrelin
antiserum exhibited 100% cross-reactivity with rat, mouse, and
human C10-ghrelin but does not recognize des-acyl-ghrelin. The
cross-reactivity of anti-C10-ghrelin antiserum against C8-ghrelin
was less than 2%. Cross-reactivity of both anti-C8- and anti-
C10-ghrelin antisera to n-butyryl, n-hexanoyl, n-lauryl, and n-
palmitoyl ghrelin was all less than 5%. The RIA for total ghrelin was
also performed as described previously for rat and mouse ghrelin
(14, 25). The antiserum used for the total ghrelin RIA recognized
all ghrelin peptides with intact C-terminal sequences irrespec-
tive of their N-terminal acylation, and exhibited complete cross-
reactivity with human, mouse, and rat forms of ghrelin. Stomach
or plasma samples for C8-ghrelin, C10-ghrelin, or total ghrelin
RIA from mice were prepared as described previously (14, 25, 27).
REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION FOR
mRNAs OF GHRELIN AND GOAT
The expression levels of mRNA for ghrelin and GOAT in stom-
achs of mice were examined using semi-quantitative reverse
transcriptase polymerase chain reaction (PCR) as described pre-
viously (28, 29). The PCR was performed using a commer-
cially available PCR kit (Go-Taq Master Mix; Promega, Madi-
son, WI, USA) with each primer set necessary to amplify
the transcripts for ghrelin (Accession No. NM_021488.4, 32
cycles, 329 bps), GOAT (Accession No. NM_001126314, 36 cycles,
141 bps), and β-actin (Accession No. XM_136101, 22 cycles,
224 bps). The sense or reverse primer for the amplification of
mouse ghrelin mRNA was 5′-AGTCCTGTCAGTG GTTACTTG-
3′ or 5′-AGGCCTGTCCGTGGTTACTTG-3′, respectively. The
sense or reverse primer for the amplification of mouse
GOAT mRNA was 5′-GGGCCAGGTACCTCTTTCTC-3′ or
5′-GCCTATGGACTTCCTGTGGA-3′, respectively. The sense
or reverse primer for the amplification of mouse β-
actin mRNA was 5′-CCTAGCACCATGAAGATCAA-3′ or 5′-
TTTCTGCACAAGTTAGG TTTTGTCAA-3′, respectively. The
NIH-Image program was used to determine the relative amount
of each PCR product after gel electrophoresis, and the amount was
normalized using simultaneously amplified β-actin (30).
STATISTICAL ANALYSIS
Data were presented as the means± SD. The statistical significance
was determined by ANOVA, two-tailed Student’s paired t -test, or
Chi-square test. A p-value< 0.05 was considered to be statistically
significant on ANOVA and Student’s t -test. A p-value< 0.016 was
considered to be statistically significant concerning the difference
among the proportion for types of secretory granules (Chi-square
test followed by Bonferroni’s procedure for multiple tests of sig-
nificance). All tests were performed using SAS version 9.2 (SAS
Institute, Cary, NC, USA).
RESULTS
BODY WEIGHTS AND DAILY FOOD INTAKE OF MICE
Body weight of mice before the treatment with MCT-containing
chow was 24.5± 1.2 g in the control group fed a standard chow
(CE-2, CREA, Japan), 24.2± 0.7 g in the C8-MCT-fed group, and
23.4± 0.6 g in the C10-MCT-fed group (n= 5 in each group).
After 2 weeks of the respective feeding regimens, body weights of
mice fed control chow, C8-MCT- and C10-MCT-containing chow
were 25.2± 1.7, 25.2± 0.9, and 24.0± 0.2 g, respectively. Among
the three groups of mice, there were no significant differences in
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body weights before or after the treatment. The average daily food
consumption (g/day) in each group was 3.36± 0.49 g for control
group, 3.18± 0.44 g for C8-MCT-fed group, and 3.06± 0.40 g for
C10-MCT-fed group. Again, there were no significant differences
in daily food consumption among these three groups. Average
body weights of mice upon fasting for 48 h (16.7± 1.8 g, n= 5)
were significantly (p< 0.05) lower than that of control mice fed
ad libitum a standard chow.
IMMUNOREACTIVITY FOR C8- OR C10-GHRELIN IN STOMACHS OF MICE
Immunopositive cells for C8-ghrelin (ip-C8-ghrelin) and C10-
ghrelin (ip-C10-ghrelin) in stomachs of control mice given
free access to standard laboratory chow, were sparsely distrib-
uted in the middle to lower part of the gastric mucosal layer,
where they were moderately abundant (Figures 1A,B). A small
amount of immunopositive cells for C8- or C10-ghrelin was
also detected in the gastric submucosal layer. No immunopos-
itive cells for C8- or C10-ghrelin were observed in the gastric
superficial epithelial layer. In control mice, the density of DAB
staining, reflecting the C10-ghrelin-immunoreactivity (ir-C10-
ghrelin), within the ip-C10-ghrelin cells was lower than that
for the C8-ghrelin-immunoreactivity (ir-C8-ghrelin) within the
C8-ghrelin-immunopositive (ip-C8-ghrelin) cells (Figures 1A,B).
FIGURE 1 | Immunohistochemistry for C8-ghrelin (A) or C10-ghrelin
(B) in fundi of stomachs in control mice. The density of DAB staining
in cells reflecting C10-ghrelin-immunoreactivity (ir-C10-ghrelin) was
lower than that of ir-C8-ghrelin (A,B). Immunofluorescence in fundi of
stomachs in control mice (C–E). Ir-C8-ghrelin (C) labeled with Alexa 555
(red), and ir-C10-ghrelin (D) labeled with Alexa 488 (green) are observed
in the same section. The yellow color in the merged image (E) indicated
a co-localization of ir-C8- and ir-C10-ghrelin. Arrowheads indicate
ghrelin-positive cells (A,B). Scale bars represent 100µm (A,B) and
represent 25µm (C–E).
In the fundic mucosa of the mouse stomach, the density of
ip-C10-ghrelin cells (21.3± 3.7 cells/mm2 mucosa) was approx-
imately one third that of ip-C8-ghrelin cells (57.5± 4.6 cells/mm2
mucosa) in the same section (Table 1).
IMMUNOFLUORESCENCE OF C8- AND C10-GHRELIN IN STOMACHS OF
MICE
Double immunostaining for ir-C8-ghrelin and ir-C10-ghrelin
revealed a co-localization of the immunoreactivity for both C8-
ghrelin (red fluorescence, Figure 1C) and C10-ghrelin (green
fluorescence, Figure 1D) within the same cells (yellow fluorescence
in the merged image, Figure 1E) in mouse stomachs fed standard
laboratory chow ad libitum. These findings clearly indicated the
co-localization of C8- and C10-ghrelin in the same cell population.
INTRACELLULAR DISTRIBUTION OF C8- OR
C10-GHRELIN-IMMUNOREACTIVITY WITHIN THE GHRELIN-PRODUCING
CELLS
Double immunogold labeling of C8-ghrelin and C10-ghrelin
revealed that, in control mice, over 70% of the secretory gran-
ules in ghrelin-producing cells possessed both large (20 nm in
diameter) and small (10 nm in diameter) particles of immuno-
gold (Figure 2). Two other types of secretory granules were
also observed in these cells, one containing only the large par-
ticles of immunogold (reflecting ir-C8-ghrelin), and the other
containing only the small particles of immunogold (reflecting ir-
C10-ghrelin). We defined these three types of secretory granules
as C8-type (possessing only the ir-C8-ghrelin), C10-type (pos-
sessing only the ir-C10-ghrelin), or mixed-type (possessing both
ir-C8 and ir-C10-ghrelin). Aside from the secretory granules in
ghrelin-producing cells, we observed an extremely small popula-
tion of Golgi-complexes that were immunopositive for C8- and/or
C10-ghrelin (Figure 2).
THE PROPORTION OF C8-TYPE, C10-TYPE, OR MIXED-TYPE SECRETORY
GRANULES WITHIN GHRELIN-PRODUCING CELLS
As shown in Figure 3, we examined the intracellular proportions
of the three types (C8-, C10-, mixed-type) of immunogold-labeled
Table 1 | Numbers of immunopositive cells for C8- or C10-ghrelin in
stomachs of mice.
ip-C8-ghrelin ip-C10-ghrelin
C8-MCT-fed 140.6±15.5**,$ 18.7±3.1#,$
C10-MCT-fed 51.4±1.9* 96.5±15.4**,#
Fasted 51.3±3.7 47.7±4.1**
Control 57.5±4.6 21.3±3.7
Data represent mean±SD for the number of immunopositive cells for C8-ghrelin
(ip-C8-ghrelin) or C10-ghrelin (ip-C10-ghrelin) per unit area (mm2) of the stom-
ach mucosa (the average value obtained from three to five sections per each
stomach) (n= 5 mice in each group). C8-MCT-fed, stomachs of mice fed with
glyceryl-tri-octanoate containing chow for 2 weeks; C10-MCT-fed, those fed with
glyceryl-tri-decanoate containing chow for 2 weeks; Fasted, those fasted for 48 h
with free access to water; Control, those fed ad libitum with standard laboratory
chow (CE-2). *p<0.05; **p<0.01 vs. values in Control; $p<0.01 vs. values in
C10-MCT-fed; #p<0.01 vs. values in Fasted.
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FIGURE 2 | Double immunogold labeling in ghrelin-producing cells in
the stomachs of control mice. Large particles of immunogold (20 nm in
diameter) or small particles of immunogold (10 nm in diameter)
demonstrated immunoreactivity for C8-ghrelin (ir-C8-ghrelin) or C10-ghrelin
(ir-C10-ghrelin), respectively. Over 70% of secretory granules in
ghrelin-producing cells exhibited both ir-C8-ghrelin and ir-C10-ghrelin
(arrowheads). Occasionally (10–20% of the secretory granules), there
appeared granules stained only for ir-C8-ghrelin reflected by large particles
(double arrows) or ir-C10-ghrelin reflected by small particles of immunogold
(single arrow) in ghrelin-producing cells. Scale bar represents 200 nm.
FIGURE 3 |The proportion of secretory granules that possessed
immunoreactivity exclusively for C8-ghrelin (C8-type, cross-hatched
column), or exclusively for C10-ghrelin (C10-type, dotted column), or
for both C8- and C10-ghrelin (mixed-type, filled column) in
ghrelin-producing cells of the stomach in control mice fed ad libitum a
standard chow (Control), in mice fasted for 48 h (fasted), or in mice
after 2-weeks ingestion of glyceryl-tri-octanoate (C8-MCT-fed) or
glyceryl-tri-decanoate (C10-MCT-fed). Data were extracted and analyzed
from approximately 250 secretory granules of ghrelin-producing cells in
each group (n= 5 mice in each group). † p<0.01; † † p<0.001 vs. control and
fasted. p<0.001 vs. control, C8-MCT-fed, and fasted. #p< 0.001 vs. control
and fasted.
granules in ghrelin-producing cells under different nutritional
conditions: fasted,C8-MCT-fed and C10-MCT-fed,and compared
them with that of control mice fed ad libitum. Ghrelin-producing
cells of control mice contained relatively small proportions of
secretory granules that were exclusively immunopositive for either
C8- or C10-ghrelin (C8-type; 13.8± 3.3%, C10-type; 9.2± 3.5%),
whereas approximately 80% (77.1± 6.4%) of the secretory gran-
ules were mixed-type. In mice fed for 2 weeks with chow con-
taining 3% glyceryl-tri-octanoate (C8-MCT-fed), the ratio of
C8-type secretory granules (38.8± 5.4%) to the total number
of ghrelin-secretory granules (the sum of C8-, C10-, and mixed-
type) increased significantly (p< 0.01) compared with the control
(13.8± 3.3%), while that of C10-type granules (6.8± 2.1%) in
C8-MCT-fed mice slightly decreased in comparison to the control
mice (9.2± 3.5%). The ratio of mixed-type secretory granules
in ghrelin-producing cells of C8-MCT-fed mice (54.4± 5.9%)
also decreased significantly (p< 0.001) compared with control
mice (77.1± 6.4%). When we fed mice with chow containing
3% glyceryl-tri-decanoate for 2 weeks (C10-MCT-fed), the ratio
of C10-type secretory granules (47.2± 6.9%) increased signifi-
cantly (p< 0.001) compared with the control (9.2± 3.5%), while
that of C8-type granules (4.6± 1.3%) in C10-MCT-fed mice
decreased significantly (p< 0.001) compared with the control
mice (13.8± 3.3%). The ratio of mixed-type secretory granules
in ghrelin-producing cells of C10-MCT-fed mice (48.1± 6.3%)
also decreased significantly (p< 0.001) relative to control mice
(77.1± 6.4%). In contrast, after fasting, there were no sig-
nificant changes in the proportions of these three types of
secretory granules (C8-type, 10.5± 2.9%; C10-type, 15.3± 3.3%;
mixed-type, 74.2± 5.3%) in comparison to those in control
mice.
THE EFFECT OF FASTING ON THE PROPORTION OF C8- OR
C10-GHRELIN-IMMUNOREACTIVITY WITHIN THE MIXED-TYPE
SECRETORY GRANULES
In control mice (fed ad libitum a standard chow), the propor-
tions of C8-ghrelin-immunoreactivity (ir-C8-ghrelin) and C10-
ghrelin-immunoreactivity (ir-C10-ghrelin) within the mixed-type
granules (as determined by the proportion of large or small parti-
cles of immunogold within the secretory granule) were 46.5± 3.0
and 53.5± 3.1%, respectively. After fasting for 48 h, the pro-
portion of ir-C8-ghrelin within the mixed-type secretory gran-
ules (reflected by the number of large particles of immuno-
gold) fell to 33.7± 2.1% of the total immunoreactivity of ghrelin
(the sum of ir-C8- and ir-C10-ghrelin reflected by the num-
ber of large and small immunogold particles). Upon fasting,
the proportion of ir-C10-ghrelin within the mixed-type secre-
tory granules, which was reflected by the number of small par-
ticles of immunogold, increased to 66.2± 1.9% of total ghrelin
immunoreactivity.
When we defined the average rate of ir-C8-ghrelin within
the mixed-type secretory granules in one of the control mice
as 1.0, and compared the relative value for the proportion of
ir-C8-ghrelin before and after fasting, the value for the rate of
ir-C8-ghrelin in fasted mice (0.76± 0.06) was significantly lower
(p< 0.001) than that in control mice (1.05± 0.07) (n= 5 mice in
each group). In contrast, the relative value for the proportion of ir-
C10-ghrelin in fasted mice (1.19± 0.05) was significantly higher
(p< 0.001) than that in control mice (0.96± 0.05) (n= 5 mice in
each group).
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Table 2 | Stomach contents of C8- or C10-ghrelin under different
nutritional conditions.
C8-ghrelin C10-ghrelin Total ghrelin
C8-MCT-fed 3.62±0.33**,#,$ 0.13±0.02*,#,$ 6.57±0.79*
C10-MCT-fed 2.70±0.36$ 1.21±0.12**,$ 6.49±0.80*
Fasted 1.63±0.32* 0.58±0.10** 6.57±0.71*
Control 2.29±0.23 0.27±0.20 7.61±0.66
Data represent mean±SD for the stomach contents (pmol/mg-tissue) of each
ghrelin molecule (C8-ghrelin, C10-ghrelin, or total ghrelin) measured by C8-ghrelin
RIA, C10-ghrelin RIA, or total ghrelin RIA (n=5 mice in each group). Control, fed
ad libitum a control laboratory chow (the same group of mice used for the electron-
and light-microscopic analysis); C8-MCT-fed, fed with chow containing glyceryl-tri-
octanoate; C10-MCT-fed, fed with chow containing glyceryl-tri-decanoate; Fasted,
fasted for 48 h with free access to water. *p<0.05; **p<0.01 vs. values in
Control. #p<0.01 vs. values in C10-MCT-fed. $p<0.01 vs. values in Fasted.
CONTENTS OF C8- OR C10-GHRELIN-IMMUNOREACTIVITY IN
STOMACHS OF MICE
As shown in Table 2, the stomach content of C8-ghrelin, as mea-
sured by C8-ghrelin RIA, was significantly larger (p< 0.01) in
C8-MCT-fed stomachs than that in control stomachs. The stom-
ach content of C10-ghrelin, which was measured by C10-ghrelin
RIA, was significantly smaller (p< 0.05) in C8-MCT-fed stom-
achs, and was significantly larger (p< 0.01) in C10-MCT-fed
stomachs compared with the controls. The stomach content of
total ghrelin (measured by total ghrelin RIA which recognized
both acyl- and des-acyl-ghrelin with intact C-termini) in both
C8-MCT-fed and C10-MCT-fed stomachs were slightly but signif-
icantly decreased (p< 0.05) compared to that of control stomachs.
Upon fasting, stomach contents of both C8-ghrelin and total
ghrelin declined significantly (p< 0.05), and that of C10-ghrelin
increased significantly (p< 0.01) than that in stomachs of control
mice.
EXPRESSION LEVELS OF mRNAs FOR GHRELIN OR GOAT IN STOMACHS
OF MICE
The relative expression levels of mRNA for ghrelin, corrected by
β-actin levels, in stomachs of fasted mice were significantly higher
(p< 0.01) than in stomachs of control mice fed ad libitum a stan-
dard laboratory chow (Table 3). However, the levels of ghrelin
mRNA in stomachs of C8-MCT or C10-MCT-fed mice did not
differ from that in control mice. The relative expression levels
of GOAT mRNA in fasted or C8-MCT-fed stomachs of mice did
not differ from that in control stomachs. Whereas, the levels of
GOAT mRNA in stomachs of C10-MCT-fed mice were signifi-
cantly (p< 0.05) lower than those in control and C8-MCT-fed
mice.
PLASMA CONCENTRATIONS OF C8- OR
C10-GHRELIN-IMMUNOREACTIVITY IN MICE
As shown in Table 4, plasma levels of C8-ghrelin increased signifi-
cantly after fasting for 48 h. In contrast, plasma levels of C8-ghrelin
did not change after the ingestion of C8-MCT for 2 weeks. Simi-
larly, the change in C10-ghrelin level after ingestion of C10-MCT
was far smaller than that seen upon fasting.
Table 3 | Expression levels of ghrelin and GOAT mRNAs in stomachs of
mice under different nutritional conditions.
Ghrelin GOAT
C8-MCT-fed 101.2±13.6 105.4±9.0
C10-MCT-fed 93.0±8.7 82.8±9.2*,$
Fasted 174.0±0.33** 103.6±18.5
Control 100.0±7.8 100.0±11.4
Data represent mean±SD for the relative expression level of mRNAs for ghre-
lin or ghrelin O-acyltransferase (GOAT) measured by semi-quantitative RT-PCRs
(n=5 mice in each group). C8-MCT-fed, fed with glyceryl-tri-octanoate contain-
ing chow; C10- MCT-fed, fed with glyceryl-tri-decanoate containing chow; Fasted,
fasted for 48 h with free access to water; Control, fed ad libitum with standard lab-
oratory chow (the same group of mice used for the electron- and light-microscopic
analysis). *p<0.05; **p< 0.01 vs. values in Control. $p<0.05 vs. values in C8-
MCT-fed. Expression level for the respective mRNAs for ghrelin, or GOAT in one
of the control mice was defined as 100.
Table 4 | Plasma ghrelin levels under different nutritional conditions.
C8-ghrelin C10-ghrelin Total ghrelin
C8-MCT-fed 25.0±5.5# 11.4±2.0## 298.4±56.2
C10-MCT-fed 21.0±5.7# 13.8±1.3## 351.8±66.4
Fasted 88.3±39.8* 45.8±23.9** 383.1±231.9
Control 21.8±7.0 9.7±2.4 330.6±132.5
Data represent mean±SD for the plasma concentrations (fmol/ml) of each ghre-
lin molecule (C8-ghrelin, C10-ghrelin, or total ghrelin) measured by C8-ghrelin RIA,
C10-ghrelin RIA, or total ghrelin RIA (n=5 mice in each group). C8-MCT-fed, fed
with glyceryl-tri-octanoate containing chow; C10-MCT-fed, fed with glyceryl-tri-
decanoate containing chow; Fasted, plasma samples from mice upon fasting for
48 h; Control, control mice fed ad libitum a standard laboratory chow. *p<0.05;
**p<0.01 vs. values in Control. #p<0.05; ##p< 0.01 vs. values in Fasted.
DISCUSSION
The present study by double immunoelectron microscopy con-
firmed our previous findings by light microscopy concerning the
co-existence of C8- and C10-ghrelin-immunoreactivity (ir-C8-
and ir-C10-ghrelin) within the same ghrelin-producing cells (14).
On immunoelectron microscopy, we observed both ir-C8- and ir-
C10-ghrelin within round and compact dense granules of X/A-like
cell type, a characteristics of ghrelin-producing cells in rats (15),
mice (18), and hamster (17).
Concerning the subcellular distribution of ir-C8- or ir-C10-
ghrelin outside of secretory granules, we did not detect any signif-
icant signals of immunogold within the endoplasmic reticulum or
Golgi complex. However, these findings did not disprove the puta-
tive concept (31) that the acylation of ghrelin by GOAT precedes
the protease cleavage of pro-ghrelin to ghrelin, because the anti-
bodies we used in this study possessed little or no cross-reactivity
to pro-ghrelin peptides irrespective of their acylation status
(12, 25).
After feeding mice with chow containing C8-MCT or C10-
MCT for 2 weeks, a significant increase was noted in the propor-
tion of C8- or C10-type secretory granules, respectively, to the total
number of ghrelin-secretory granules in ghrelin-producing cells,
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while the proportion of mixed-type granules to the total number
of ghrelin-secretory granules in ghrelin-producing cells declined
significantly. These findings suggested that a certain proportion
(10–20%) of the mixed-type secretory granules changed to C8-
type or C10-type after a feeding regimen containing C8-MCT or
C10-MCT, respectively. These findings also implied that the type
of medium-chain acyl-molecules (i.e., C8-CoA or C10-CoA) sur-
rounding the ghrelin-GOAT system has strong effect on the type
of acyl-ghrelins (i.e., C8-ghrelin or C10-ghrelin) stored within the
ghrelin-secretory granules.
When we evaluated the stomach contents of ir-C8- or ir-C10-
ghrelin by RIA, the levels of ir-C10-ghrelin increased significantly
in both C10-MCT-fed and fasted conditions, which was in line
with previous reports (11–14, 21). In contrast, upon fasting, the
ratios of secretory granules (C8-, C10-, or mixed-type) to the total
number of ghrelin-secretory granules in ghrelin-producing cells
did not differ from those in control mice fed ad libitum. However,
in the same ghrelin-producing cells of fasted mice, we detected
a significant increase in the proportion of ir-C10-ghrelin and a
significant decline in the proportion of ir-C8-ghrelin within the
mixed-type granules. On the other hand, we could not detect any
significant change in the proportions of ir-C8- or ir-C10-ghrelin
within the mixed-type granules after feeding mice with C8- or
C10-MCT-containing chow for 2 weeks (data not shown here).
These differences in the subcellular distribution of ir-C8- or ir-
C10-ghrelin together with its kinetics under different nutritional
conditions, such as fasting or constant feeding with C8- or C10-
MCT, might offer important clues on the subcellular process of
ghrelin acylation.
Two-weeks treatment with C8- or C10-MCT did not alter the
expression levels of ghrelin mRNA in mouse stomachs, which was
supported by our previous report (13). As for GOAT mRNA, no
significant changes were detected except for a slight but signif-
icant decline after 2-weeks treatment with C10-MCT. Although
the precise mechanism of suppression of GOAT mRNA level by
C10-MCT-feeding remains to be solved, the influence of ghrelin
and/or GOAT mRNA levels on the subcellular kinetics of ir-C8-
or ir-C10-ghrelins appeared to be limited.
Differences in the dynamics of plasma ghrelin levels upon
different nutritional conditions examined (i.e., upon fasting or
2 weeks feeding with MCT-containing chow), which may reflect
the release of ghrelin from secretory granules into circulation,
should also be considered to be one of the key processes governing
the changes of ir-C8- or ir-C10-ghrelin within the secretory gran-
ule. In fact, changes in the level of C8- or C10-ghrelin in plasma
upon fasting were far larger than those seen after feeding mice with
chow containing C8-MCT or C10-MCT.
Based on the above findings, especially on those revealed by
our double immunoelectron microscopy, one may speculate that
the mechanism underlining ghrelin acylation is complicated, and
cannot be explained simply by the enzymatic activity of GOAT
within ghrelin-producing cells. However, our immunoelectron
microscopic study on ghrelin acylation also has several limita-
tions. Within the mixed-type secretory granules, relatively larger
proportion of ir-C10-ghrelin was observed as compared with ir-
C8-ghrelin. This finding, however, did not reflect the absolute
content of ir-C8-, or ir-C10-ghrelin in the mixed-type granule,
since we used different antibodies possessing different affinities
to the C8- or C10-forms of acyl-ghrelin. In our study, we only
compared the subcellular distribution of ir-C10- or ir-C8-ghrelin
and changes in this distribution under different nutritional con-
ditions, and did not look at the distribution or the changes of
other acyl-ghrelins including n-hexanoyl ghrelin, an intriguing
molecule whose production rate catalyzed by GOAT in vitro is far
higher than that of C10-ghrelin (9, 10), while it’s biological activity
is far smaller than that of C10- or C8-ghrelin (21, 32).
In conclusion, in this study we investigated changes in the
subcellular distribution of ir-C8- or C10-ghrelin under differ-
ent nutritional conditions by double immunoelectron microscopy.
Present findings indicated that there existed several steps for the
synthesis of acyl-ghrelins within ghrelin-secretory granules, and
also implied that the types of medium-chain acyl-molecules sur-
rounding the ghrelin-GOAT system affect the acylation process
of ghrelin. Further study using immunoelectron microscopy on
the subcellular distribution of acyl-ghrelins will shed light on the
mechanism underlining the acylation process of ghrelin.
REFERENCES
1. Kojima M, Hosoda H, Date Y,
Nakazato M, Matsuo H, Kangawa
K. Ghrelin is a growth-hormone-
releasing acylated peptide from
stomach. Nature (1999) 402:656–
60. doi:10.1038/45230
2. Hosoda H, Kojima M, Mizushima
T, Shimizu S, Kangawa K. Struc-
tural divergence of human ghrelin.
Identification of multiple ghrelin-
derived molecules produced
by post-translational process-
ing. J Biol Chem (2003) 278:
64–70. doi:10.1074/jbc.M20536
6200
3. Kojima M, Kangawa K.
Ghrelin: structure and func-
tion. Physiol Rev (2005) 85:
495–522. doi:10.1152/physrev.
00012.2004
4. Hofmann K. A superfam-
ily of membrane-bound
O-acyltransferases with implica-
tions for wnt signaling. Trends
Biochem Sci (2000) 25:111–2.
doi:10.1016/S0968-0004(99)01
539-X
5. Al Massadi O, Tschop MH,
Tong J. Ghrelin acylation and
metabolic control. Peptides
(2011) 32:2301–8. doi:10.1016/
j.peptides.2011.08.020
6. Yang J, Brown MS, Liang G,
Grishin NV, Goldstein JL. Iden-
tification of the acyltransferase
that octanoylates ghrelin, an
appetite-stimulating peptide hor-
mone. Cell (2008) 132:387–96.
doi:10.1016/j.cell.2008.01.017
7. Gutierrez JA, Solenberg PJ,
Perkins DR, Willency JA,
Knierman MD, Jin Z, et al. Ghrelin
octanoylation mediated by an
orphan lipid transferase. Proc Natl
Acad Sci U S A (2008) 105:
6320–5.
doi:10.1073/pnas.0800708105
8. Yang J, Zhao TJ, Goldstein JL,
Brown MS. Inhibition of ghre-
lin O-acyltransferase (GOAT) by
octanoylated pentapeptides. Proc
Natl Acad Sci U S A (2008) 105:
10750–5. doi:10.1073/pnas.08053
53105
9. Ohgusu H, Shirouzu K,
Nakamura Y, Nakashima Y,
Ida T, Sato T, et al. Ghrelin
O-acyltransferase (GOAT) has
a preference for n-hexanoyl-
CoA over n-octanoyl-CoA as
an acyl donor. Biochem Bio-
phys Res Commun (2009) 386:
153–8. doi:10.1016/j.bbrc.2009.
06.001
10. Ohgusu H, Takahashi T, Kojima
M. Enzymatic characterization of
GOAT, ghrelin O-acyltransferase.
Methods Enzymol (2012)
514:147–63. doi:10.1016/B978-0-
12-381272-8.00010-6
11. Kirchner H, Gutierrez JA, Solen-
berg PJ, Pfluger PT, Czyzyk
TA, Willency JA, et al. GOAT
links dietary lipids with the
endocrine control of energy bal-
ance. Nat Med (2009) 15:741–5.
doi:10.1038/nm.1997
12. Nishi Y, Yoh J, Hiejima H,
Kojima M. Structures and
molecular forms of the ghrelin-
family peptides. Peptides
(2011) 32:2175–82. doi:10.
1016/j.peptides.2011.07.024
www.frontiersin.org July 2013 | Volume 4 | Article 84 | 7
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Nishi et al. Double immunoelectron microscopy for C8- and C10-ghrelin
13. Nishi Y, Hiejima H, Hosoda H,
Kaiya H, Mori K, Fukue Y, et
al. Ingested medium-chain fatty
acids are directly utilized for
the acyl modification of ghrelin.
Endocrinology (2005) 146:2255–
64. doi:10.1210/en.2004-0695
14. Hiejima H, Nishi Y, Hosoda
H, Yoh J, Mifune H, Satou
M, et al. Regional distribu-
tion and the dynamics of n-
decanoyl ghrelin, another acyl-
form of ghrelin, upon fasting in
rodents. Regul Pept (2009) 156:
47–56. doi:10.1016/j.regpep.2009.
05.003
15. Date Y, Kojima M, Hosoda
H, Sawaguchi A, Mondal MS,
Suganuma T, et al. Ghrelin, a
novel growth hormone-releasing
acylated peptide, is synthesized
in a distinct endocrine cell type
in the gastrointestinal tracts of
rats and humans. Endocrinol-
ogy (2000) 141:4255–61.
doi:10.1210/en.141.11.4255
16. Rindi G, Necchi V, Savio A,
Torsello A, Zoli M, Locatelli
V, et al. Characterisation of
gastric ghrelin cells in man
and other mammals: studies in
adult and fetal tissues. His-
tochemCell Biol (2002) 117:511–9.
doi:10.1007/s00418-002-0415-1
17. Yabuki A, Ojima T, Kojima
M, Nishi Y, Mifune H, Mat-
sumoto M, et al. Characteriza-
tion and species differences in
gastric ghrelin cells from mice,
rats and hamsters. J Anat (2004)
205:239–46. doi:10.1111/j.0021-
8782.2004.00331.x
18. Tomasetto C, Karam SM,
Ribieras S, Masson R, Lefebvre
O, Staub A, et al. Identifica-
tion and characterization of a
novel gastric peptide hormone:
the motilin-related peptide.
Gastroenterology (2000) 119:395–
405. doi:10.1053/gast.2000.9371
19. Zhao CM, Furnes MW, Sten-
strom B, Kulseng B, Chen D.
Characterization of obestatin- and
ghrelin-producing cells in the gas-
trointestinal tract and pancreas
of rats: an immunohistochemical
and electron-microscopic study.
Cell Tissue Res (2008) 331:575–87.
doi:10.1007/s00441-007-0514-3
20. Toshinai K, Mondal MS, Nakazato
M, Date Y, Murakami N, Kojima
M, et al. Upregulation of Ghre-
lin expression in the stomach
upon fasting, insulin-induced
hypoglycemia, and leptin admin-
istration. Biochem Biophys Res
Commun (2001) 281:1220–5.
doi:10.1006/bbrc.2001.4518
21. Nishi Y, Mifune H, Kojima M.
Ghrelin acylation by ingestion of
medium-chain fatty acids. Meth-
ods Enzymol (2012) 514:303–15.
doi:10.1016/B978-0-12-381272-
8.00019-2
22. Mifune H, Richter R, Forss-
mann WG. Detection of
immunoreactive atrial and
brain natriuretic peptides in the
equine atrium. Anat Embryol
(Berl) (1995) 192:117–21. doi:10.
1007/BF00186000
23. Mayhew TM, Lucocq JM.
Multiple-labelling immunoEM
using different sizes of colloidal
gold: alternative approaches
to test for differential distri-
bution and colocalization in
subcellular structures. Histochem
Cell Biol (2011) 135:317–26.
doi:10.1007/s00418-011-0788-0
24. Namba K, Suzuki T, Nakata
H. Immunogold electron
microscopic evidence of
in situ formation of homo-
and heteromeric puriner-
gic adenosine A1 and P2Y2
receptors in rat brain. BMC
Res Notes (2010) 3:323.
doi:10.1186/1756-0500-3-323
25. Hosoda H, Kojima M, Matsuo
H, Kangawa K. Ghrelin and
des-acyl ghrelin: two major
forms of rat ghrelin pep-
tide in gastrointestinal tissue.
Biochem Biophys Res Commun
(2000) 279:909–13. doi:10.1006/
bbrc.2000.4039
26. Nishi Y, Hiejima H, Mifune H,
Sato T, Kangawa K, Kojima M.
Developmental changes in the pat-
tern of ghrelin’s acyl modification
and the levels of acyl-modified
ghrelins in murine stomach.
Endocrinology (2005) 146:2709–
15. doi:10.1210/en.2004-0645
27. Yoh J, Nishi Y, Hosoda H, Tajiri
Y, Yamada K, Yanase T, et al.
Plasma levels of n-decanoyl ghre-
lin, another acyl- and active-
form of ghrelin, in human sub-
jects and the effect of glucose-
or meal-ingestion on its dynam-
ics. Regul Pept (2011) 167:140–8.
doi:10.1016/j.regpep.2010.12.010
28. Hamada N, Nishi Y, Tajiri Y,
Setoyama K, Kamimura R, Miya-
hara K, et al. Disrupted reg-
ulation of ghrelin production
under antihypertensive treatment
in spontaneously hypertensive
rats. Circ J (2012) 76:1423–9.
doi:10.1253/circj.CJ-11-1345
29. Mifune H, Nishi Y, Tajiri Y,
Masuyama T, Hosoda H, Kan-
gawa K, et al. Increased produc-
tion of active ghrelin is relevant to
hyperphagia in nonobese sponta-
neously diabetic Torii rats. Metab-
olism (2012) 61:491–5. doi:10.
1016/j.metabol.2011.09.001
30. Nishi Y, Haji M, Takayanagi
R, Iguchi H, Shimazoe T,
Hirata J, et al. Establishment
and characterization of
pthrp-producing human
pancreatic-cancer cell-line.
Int J Oncol (1994) 5:33–9.
31. Kojima M, Kangawa K. Ghre-
lin: from gene to physiological
function. Results Probl Cell
Differ (2010) 50:185–205.
doi:10.1007/400_2009_28
32. Matsumoto M, Hosoda H, Kita-
jima Y, Morozumi N, Minami-
take Y, Tanaka S, et al. Structure-
activity relationship of ghrelin:
pharmacological study of ghre-
lin peptides. Biochem Biophys
Res Commun (2001) 287:142–6.
doi:10.1006/bbrc.2001.5553
Conflict of Interest Statement: The
authors declare that the research was
conducted in the absence of any com-
mercial or financial relationships that
could be construed as a potential con-
flict of interest.
Received: 29 March 2013; accepted: 26
June 2013; published online: 09 July 2013.
Citation: Nishi Y, Mifune H, Yabuki A,
Tajiri Y, Hirata R, Tanaka E, Hosoda
H, Kangawa K and Kojima M (2013)
Changes in subcellular distribution of n-
octanoyl or n-decanoyl ghrelin in ghrelin-
producing cells. Front. Endocrinol. 4:84.
doi: 10.3389/fendo.2013.00084
This article was submitted to Frontiers in
Experimental Endocrinology, a specialty
of Frontiers in Endocrinology.
Copyright © 2013Nishi,Mifune,Yabuki,
Tajiri, Hirata, Tanaka, Hosoda, Kan-
gawa and Kojima. This is an open-
access article distributed under the terms
of the Creative Commons Attribution
License, which permits use, distribution
and reproduction in other forums, pro-
vided the original authors and source
are credited and subject to any copy-
right notices concerning any third-party
graphics etc.
Frontiers in Endocrinology | Experimental Endocrinology July 2013 | Volume 4 | Article 84 | 8
